Harmonic Announces Series A Funding Round To Accelerate Development of Mathematical Superintelligence
Recogni Raises $102 Million to Advance Next Generation AI Inference System for Generative AI and Intelligent Autonomy
Excision BioTherapeutics Initiates Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
Sirona Medical Secures $40M in Series B Funding, Accelerating the Adoption of its Cloud-Native Radiology Operating System
Hero Foods Launches Partnership with Subway, offering One-Net Carb Bread backed by Tom Brady
Carrum Health Expands into Nevada Through Partnership with Crovetti Orthopaedics
Sidecar Health Raises $125 Million to Scale “Cash Price” Health Insurance Offering
Namogoo Launches First-of-its-Kind Intent-Based Promotion Machine for eCommerce, Individualizing Incentives for Every Site Visit & Guaranteeing Digital Journey Continuity
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
Datalogz Secures $5 Million Funding Led by GreatPoint Ventures, Unveiling Their Groundbreaking Solution to End Business Intelligence (BI) Sprawl Across Fortune 500 Enterprises
Recogni claims world’s fastest computing system for autonomous driving
Onymos raises $12M, led by GreatPoint Ventures, to provide plug-in features for apps
LA-based Sidecar Health’s low-cost, cash-pay health insurance service is now valued at $1 billion
Hacking Postgres: DJ Patil and Ray Lane Interview, GreatPoint Ventures -- YouTube
Pete Soderling's Zero Prime Podcast: Episode 13 with DJ Patil. Pete and DJ speak about all things data!
Examining the "Integration Layer" - Breaking down GreatPoint's investment in Onymos
Ep. 9 R K Anand, CEO & Co-Founder, Recogni
Join the BMW iVentures team as they speak with CEO and Co-Founder of Recogni, RK Anand, on the company’s advancement of visual-perception technology in autonomous vehicles.
Episode 2: Interview with our Co-founder and Chief Business Officer, Ashwini Choudhary
Q&A with Tailored Brands: How they Adapted Omnichannel Retail to the COVID-19 Era